Notification of Full Year Results Date

RNS Number : 3365H

e-Therapeutics plc

12 March 2018

 

e-Therapeutics plc

("e-Therapeutics" or the "Company")

Notification of Full Year Results Date

Oxford, UK - 12 March 2018 - e-Therapeutics plc (AIM: ETX), a company using Network-Driven Drug Discovery (NDD) to create new and better drugs, will announce its full year results for the year ended 31 January 2018 on Tuesday, 27 March 2018.

-Ends-

For more information, please contact:

e-Therapeutics plc Raymond Barlow, CEO Steve Medlicott, Finance Director	Tel: [phone] www.etherapeutics.co.uk
Numis Securities Limited Michael Meade / Freddie Barnfield (Corporate Finance) James Black (Corporate Broking)	Tel: [phone] www.numis.com
Instinctif Partners Melanie Toyne Sewell / Alex Shaw / Deborah Bell	Tel: [phone] Email: [e-mail]

About e-Therapeutics plc

e-Therapeutics is an Oxford-based company with a unique and powerful computer-based drug discovery platform and a specialised approach to network biology. 

Its novel methodology and Discovery Engine allow the Company to discover new and better drugs in a more efficient and effective way.

For more information about the Company, please visit www.etherapeutics.co.uk

 

END

 

 

NORBXGDXCSBBGIB